Trial Profile
A Phase III, Multicenter, Open Label, Randomized Study of Bovine Rotavirus Pentavalent Vaccine (BRV-PV) to Evaluate Lot-To-Lot Consistency and to Investigate Potential Interference With Routine UIP Vaccinations in Healthy Infants in India
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 01 Dec 2018
Price :
$35
*
At a glance
- Drugs Bovine rotavirus vaccine reassortant (Primary) ; Hib-DTaP-hepatitis B vaccine; Poliovirus vaccine; Rotavirus vaccine
- Indications Rotavirus infections
- Focus Pharmacodynamics; Registrational
- 09 Nov 2018 Results assessing safety and immunogenecity published in the Vaccine.
- 27 Sep 2018 According to a PATH media release, ROTASIIL achieved World Health Organization's (WHO's) prequalification Based on data from this and another study CTP700300192.
- 03 Oct 2017 Status changed from active, no longer recruiting to completed.